Wall Street opens higher after massive drop

By
March 3, 2009 16:48

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

Wall Street opened higher in early trading after a massive sell-off and as the government announced details of a program designed to boost availability of credit. The Federal Reserve plans to lend up to $200 billion initially to spur consumer and small business borrowing for autos, education, credit cards and other expenses. The central bank announced the plan late last year. Some rebound has been expected because of the heavy selling seen Monday that sent the Dow Jones industrial average below 7,000 for the first time since May 1997. The Dow was up 79 at 6,840. The Standard & Poor's 500 index was up 10 at 710, and the Nasdaq composite index was up 20 at 1,343.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS